KLF8 and osteosarcoma: For instance, a decrease in KLF8 expression slows down the proliferation of differentiated cells (cancerous osteoblasts) or metastases in osteosarcomas [62], and FHL2 positively affects osteoblastogenesis, bone formation, and bone mass [35].